A retinal artery occlusion is a blockage in one of the blood vessels that supplies your retina with blood. It usually occurs suddenly and can cause vision loss without causing pain. A retinal artery ...
New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ...
Because the left and right eyes are set apart, points in the scene are projected to slightly different locations on the two eyes' retinal images. Disparity is defined as the vector difference in ...
Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive new data from two global phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) in macular edema ...
Basel, 1 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) in macular edema due ...
"Central Retinal Vein Occlusion Pipeline Insight"The Central Retinal Vein Occlusion (CRVO) treatment landscape is advancing, with several companies developing novel therapies to improve outcomes. CRVO ...
Vabysmo is the first bispecific antibody approved to treat ocular conditions such as diabetic macular edema and wet age-related macular degeneration. “This is the first time that vision and anatomical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback